Propeller Health, a Madison, Wis.-based digital solution for respiratory medicine, closed a $21.5m Series C financing.
Backers included new investors 3M Ventures (NYSE: MMM), SR One, Hikma Ventures (LON: HIK), Safeguard Scientifics (NYSE: SFE), Social Capital.
The company intends to use the funds to expand its platform.
Led by David Van Sickle, CEO, Propeller provides a digitally-guided therapy platform that integrates information from multiple sources, including connected medications, then uses machine intelligence to recommend an optimal path of therapy for each individual.
With the majority of inhaled medications now connected to its software platform, Propeller has grown over the last 12 months with over 45 programs signed with healthcare systems such as Dignity Health and Nemours Children’s Health System, managed care organizations such as Molina Healthcare and innovative at-risk entities such as ChenMed.